As of 2026-05-03, the Intrinsic Value of Pro Medicus Ltd (PME.AX) is 40.86 AUD. This PME.AX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 136.16 AUD, the upside of Pro Medicus Ltd is -70.00%.
The range of the Intrinsic Value is 24.62 - 157.65 AUD
Based on its market price of 136.16 AUD and our intrinsic valuation, Pro Medicus Ltd (PME.AX) is overvalued by 70.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 24.62 - 157.65 | 40.86 | -70.0% |
| DCF (Growth 10y) | 34.14 - 222.04 | 57.23 | -58.0% |
| DCF (EBITDA 5y) | 38.02 - 50.82 | 43.64 | -67.9% |
| DCF (EBITDA 10y) | 47.03 - 74.29 | 58.50 | -57.0% |
| Fair Value | 56.16 - 56.16 | 56.16 | -58.75% |
| P/E | 20.73 - 60.30 | 38.30 | -71.9% |
| EV/EBITDA | 27.05 - 36.57 | 31.25 | -77.0% |
| EPV | 9.83 - 16.36 | 13.09 | -90.4% |
| DDM - Stable | 19.47 - 180.28 | 99.88 | -26.6% |
| DDM - Multi | 20.06 - 146.86 | 35.51 | -73.9% |
| Market Cap (mil) | 14,224.63 |
| Beta | 1.26 |
| Outstanding shares (mil) | 104.47 |
| Enterprise Value (mil) | 14,040.74 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.60% |
| Cost of Debt | 5.50% |
| WACC | 8.60% |